Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950123-10-021065
Filing Date
2010-03-04
Accepted
2010-03-04 17:06:35
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A b79899e10vkza.htm 10-K/A 2796184
2 EX-21.1 LIST OF SUBSIDIARIES OF THE COMPANY b79899exv21w1.htm EX-21.1 37941
3 EX-23.1 CONSENT OF BDO SEIDMAN, LLP b79899exv23w1.htm EX-23.1 2016
4 EX-31.1 SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER b79899exv31w1.htm EX-31.1 5856
5 EX-31.2 SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER b79899exv31w2.htm EX-31.2 6147
6 EX-32.1 SECTION 906 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL b79899exv32w1.htm EX-32.1 4124
7 GRAPHIC b79899b7989901.gif GRAPHIC 9069
  Complete submission text file 0000950123-10-021065.txt   2866356
Mailing Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453
Business Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453 7816473900
INVERNESS MEDICAL INNOVATIONS INC (Filer) CIK: 0001145460 (see all company filings)

EIN.: 043565120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-16789 | Film No.: 10657943
SIC: 2835 In Vitro & In Vivo Diagnostic Substances